Lataa...
LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha.
LMP-1, an Epstein-Barr virus membrane protein expressed during latent infection, has oncogenic properties, as judged from its ability to transform B lymphocytes and rodent fibroblasts. LMP-1 induces the expression of bcl2, an oncogene which protects cells from apoptosis, as well as of genes encoding...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1995
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC188885/ https://ncbi.nlm.nih.gov/pubmed/7884865 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|